Episode 46

HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review

Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics:

  • Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00)
  • Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07)
  • Case: A man in his mid 80s experiences metastatic recurrence after resection of PD-L1-positive, HER2-mutant metastatic NSCLC (17:50)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free